Literature DB >> 23772720

Determining the precision of dual energy x-ray absorptiometry and bioelectric impedance spectroscopy in the assessment of breast cancer-related lymphedema.

Anne L Newman1, Leonard Rosenthall, Anna Towers, Pamela Hodgson, Carol A Shay, Dorit Tidhar, Antonio Vigano, Robert D Kilgour.   

Abstract

BACKGROUND: The composition of breast cancer-related lymphedema (BCRL) has been shown to evolve from the initial accumulation of fluid to the development of fibrotic lesions and abnormal fat deposition. Therefore, precise and reliable assessments of BCRL are required to develop accurate staging and management. Although dual energy x-ray absorptiometry (DXA) and bioelectric impedance spectroscopy (BIS) have been used to assess BCRL, no study has evaluated the precision of these two modalities in the same cohort. METHODS AND
RESULTS: We determined the precision of DXA and BIS in lymphedematous (LE) and nonaffected (NA) arms of 24 women with Stage II unilateral BCRL. Precision was calculated from the results of paired bilateral arm measurements obtained from DXA scans measuring fat, lean, and bone mineral masses, BIS measuring extracellular fluid (ECF) and total fluid volume, and circumferential tape measurements (CM) of the arms to calculate the anatomic volume. Precision error was expressed as the root mean square (RMS) of the coefficients of variation (%CV) and standard deviations (SD).
RESULTS: The precisions of DXA and BIS varied from 1.16% (DXA measurements of LE arm total volume) to 1.86% (BIS LE arm total fluid volume) and from 0.95% (DXA lean mass of NA arm) to 1.72% (DXA BMC of NA arm). Precision of CM measures of arm volume were 1.71% CV for LE arm and 2.51% CV for NA arm. The fat and lean masses of the LE arm exceeded the NA arm by about 15% (p<0.0001). ECF and total fluid volume of LE arm was 22.6% and 19% greater than the NA arm (p<0.0001), respectively.
CONCLUSION: For BCRL, these findings suggest that DXA and BIS are two measurement instruments that provide acceptable levels of precision for the measurement of arm lean mass, fat mass and ECF volume, respectively.

Entities:  

Mesh:

Year:  2013        PMID: 23772720     DOI: 10.1089/lrb.2012.0020

Source DB:  PubMed          Journal:  Lymphat Res Biol        ISSN: 1539-6851            Impact factor:   2.589


  10 in total

Review 1.  Bridging the divide between pathogenesis and detection in lymphedema.

Authors:  J Brandon Dixon; Michael J Weiler
Journal:  Semin Cell Dev Biol       Date:  2014-12-26       Impact factor: 7.727

2.  Use of Dual-Energy X-Ray Absorptiometry to Assess Soft Tissue Composition in Breast Cancer Survivors With and Without Lymphedema.

Authors:  Betty J Smoot; Judy Mastick; John Shepherd; Steven M Paul; Kord M Kober; Bruce A Cooper; Yvette P Conley; Niharika Dixit; Marilyn J Hammer; Mei R Fu; Gary Abrams; Christine Miaskowski
Journal:  Lymphat Res Biol       Date:  2021-11-18       Impact factor: 2.349

3.  A new soft tissue volume measurement strategy using ultrasonography.

Authors:  Ji Hye Hwang; Chang-Hyung Lee; Hae Hyun Lee; Soo Yeon Kim
Journal:  Lymphat Res Biol       Date:  2014-02-12       Impact factor: 2.589

4.  Magnetic Resonance Imaging-Based Assessment of Breast Cancer-Related Lymphoedema Tissue Composition.

Authors:  Marco Borri; Kristiana D Gordon; Julie C Hughes; Erica D Scurr; Dow-Mu Koh; Martin O Leach; Peter S Mortimer; Maria A Schmidt
Journal:  Invest Radiol       Date:  2017-09       Impact factor: 6.016

5.  Diagnosis of Upper-Quadrant Lymphedema Secondary to Cancer: Clinical Practice Guideline From the Oncology Section of APTA.

Authors:  Kimberly Levenhagen; Claire Davies; Marisa Perdomo; Kathryn Ryans; Laura Gilchrist
Journal:  Rehabil Oncol       Date:  2017-06-30

Review 6.  Diagnosis of Upper Quadrant Lymphedema Secondary to Cancer: Clinical Practice Guideline From the Oncology Section of the American Physical Therapy Association.

Authors:  Kimberly Levenhagen; Claire Davies; Marisa Perdomo; Kathryn Ryans; Laura Gilchrist
Journal:  Phys Ther       Date:  2017-07-01

7.  Current practice trends of oedema management in the hands of people with tetraplegia in Australia.

Authors:  Soo Oh; Louise Gustafsson; Sally Eames
Journal:  Spinal Cord Ser Cases       Date:  2019-08-07

8.  A randomized cross-over trial to detect differences in arm volume after low- and heavy-load resistance exercise among patients receiving adjuvant chemotherapy for breast cancer at risk for arm lymphedema: study protocol.

Authors:  Kira Bloomquist; Sandi Hayes; Lis Adamsen; Tom Møller; Karl Bach Christensen; Bent Ejlertsen; Peter Oturai
Journal:  BMC Cancer       Date:  2016-07-22       Impact factor: 4.430

Review 9.  Lymphedema in survivors of breast cancer.

Authors:  Lin He; Huili Qu; Qian Wu; Yuhua Song
Journal:  Oncol Lett       Date:  2020-01-16       Impact factor: 2.967

10.  Liposuction of Breast Cancer-Related Arm Lymphedema Reduces Fat and Muscle Hypertrophy.

Authors:  Tobias Karlsson; Magnus Karlsson; Karin Ohlin; Gaby Olsson; Håkan Brorson
Journal:  Lymphat Res Biol       Date:  2021-03-02       Impact factor: 2.589

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.